Safety of intranasal Bevacizumab (avastin) treatment in patients with hereditary hemorrhagic telangiectasia‐associated epistaxis (Q37846182)
Jump to navigation
Jump to search
scientific article published on November 11, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety of intranasal Bevacizumab (avastin) treatment in patients with hereditary hemorrhagic telangiectasia‐associated epistaxis |
scientific article published on November 11, 2010 |
Statements
1 reference
Safety of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis (English)
1 reference
Safety of intranasal Bevacizumab (avastin) treatment in patients with hereditary hemorrhagic telangiectasia‐associated epistaxis (English)
1 reference
Sonia Chen
1 reference
Tom Karnezis
1 reference
Terence M. Davidson
11 November 2010
1 reference
1 reference
1 reference
121
1 reference
3
1 reference
644-646
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference